Compliance with hormone therapy.

Keywords

Medicine, Tolerability, Intensive care medicine, Osteoporosis, Hormone replacement therapy (female-to-male)

References

• Effects of long-term estrogen replacement therapy. II. Neoplasia.Charles B. Hammond, Frederick R. Jelovsek, Kerry L. Lee — 1979
• Decreased risk of fractures of the hip and lower forearm with postmenopausal use of estrogen.Noel S. Weiss, Carol L. Ure, Jude H. Ballard — 1980
• Physicians' Judgments About Estrogen Replacement Therapy for Menopausal WomenGerald B. Holzman, Michael M. Ravitch, William P. Metheny — 1984
• Comparative acceptance of three transdermal nitroglycerin placebo patches.Carolyn M. Rayment, Alan F. Kaul, Joseph M. Garfield — 1985

Cited by

• Comparative study on reduction of bone loss and lipid metabolism abnormality in ovariectomized rats by soy isoflavones, daidzin, genistin, and glycitin.Zsófia Ruttkay — 2001
• Menopause and osteoporosis: the role of HRT.Deborah Stier Carson — 1996
• Treating hot flushes without hormone replacement therapy.Machelle M Seibel — 2003
• Menopause and quality of lifeAlain Leplège, Lorraine Dennerstein — 2000
• Use of hormone replacement therapy in Washington State: is prevention being put into practice?B. G. Saver, Thomas R. Taylor, Nancy Fúgate Woods — 1999
• Menopause and treatmentsVirginie Ringa — 2004
• Effects of vehicle supplementation on total estradiol absorption from a transdermal estradiol delivery system.Reginald Smith, Denise E. Robinson, Bruno Delignieres — 1991
• Hormone replacement therapy and breast cancer, endometrial cancer and cardiovascular disease: risks and benefits.Maria Goddard — 1992
• Osteoporosis in women: prevention and treatment.Laurie A. Willhite — 1998
• Factors determining the use of hormone replacement therapy in recent naturally postmenopausal women participating in the French SU.VI.MAX cohortS. Mohammed-Cherif, S. Briançon, G. Potier de Courcy — 2000
• A RANDOMISED STUDY TO COMPARE THE EFFICACY AND SAFETY OF A NEW 17β‐OESTRADIOL TRANSDERMAL MATRIX PATCH WITH ESTRADERM TTS 50 IN HYSTERECTOMISED POSTMENOPAUSAL WOMENF al-Azzawi, Marius J. van der Mooren, Rosalind M. Rolland — 1997
• Informed consent: its origins, purpose, problems, and limitsNancy M. Kettle — 2002
• Knowledge, attitudes and management strategies in Scandinavia concerning hormone replacement therapy: a comparison between gynecologists in Denmark, Norway and Sweden.Stein Tore Nilsen, Anette Tønnes Pedersen, Mette Haase Moen — 2001
• Hormone replacement therapy: knowledge, attitudes, self-reported use - and sales figures in Nordic women.A. J. Søgaard, Anne Tollan, Gro K.R Berntsen — 2000
• Atlas of OsteoporosisEric Orwoll — 2003
• Use of hormone replacement therapy among cardiac patients at a Canadian academic centre.Michelle Wise, Donna E. Stewart, Peter Liu — 1999
• Does raloxifene reduce postmenopausal women's risk of breast cancer?Ra K. Han, Nicholas Pimlott, Ruth Heisey — 2000
• Dietary n‐3 Fatty Acids Decrease Osteoclastogenesis and Loss of Bone Mass in Ovariectomized MiceDongxu Sun, Aparna Krishnan, Khaliquz Zaman — 2003
• Plasma Concentration of Estradiol After Transdermal Administration of Systen®50 (Evorel®) or Menorest®50Charla M. Blacker, N Brion, F. Caulin — 1996
• Side effects and sociobehavioral factors associated with the discontinuation of hormone therapy in a Massachusetts health maintenance organizationRobert F. Reynolds, Carla Makhlouf Obermeyer, Alexander M. Walker — 2001

Related papers

• The effects of oestrogens and progestogens on the postmenopausal endometrium.Malcolm Whitehead — 1978
• Transvaginal color Doppler assessment of endometrial status in normal postmenopausal women: the effect of hormone replacement therapy.Fernando Bonilla‐Musoles, M J Ballester, M C Martí — 1995
• The modifying effect of progestogen on the response of the post-menopausal endometrium to exogenous oestrogens.S. Campbell, John McQueen, Joseph Minardi — 1978
• Relapse Risk of Endometrial Hyperplasia After Treatment With the Levonorgestrel-Impregnated Intrauterine System or Oral ProgestogensAnne Ørbo, Marit Arnes, Anne Beate Vereide — 2016
• Endometrial cancer and HRTDavid Sturdee — 2005
• Is combined estrogen/progestogen hormone therapy worth the risk?David Sturdee, Alastair H. MacLennan — 2003
• Hormone Replacement Therapy at the Menopause A Double Blind Controlled Study of Women's PreferencesLorraine Dennerstein, Graham D. Burrows, Jean Senior — 1978
• Update on hormone replacement therapy.R. Don Gambrell — 1992